'AI Ghost Trade' Fears Slam CrowdStrike, Palo Alto Stock - But Dan Ives Sees Winners
Cybersecurity stocks are getting hit by what Wedbush Securities’ Dan Ives calls an "AI Ghost Trade" — but the firm believes investors are misreading the threat.
Shares of Crowdstrike Holdings Inc (NASDAQ:CRWD), Palo Alto Networks Inc (NASDAQ:PANW), and Zscaler Inc (NASDAQ:ZS) have come under pressure following the release of new AI-driven security tools, as investors worry artificial intelligence could disrupt traditional cyber vendors. These stocks are down 17%, 13% and 17%, respectively, over the past five days alone.
Ives said those fears have created a "huge disconnected overhang" on the sector, arguing the selloff reflects panic rather than fundamentals.
‘AI Ghost Trade' Driving Cyber Selloff
The concern stems from rapid advances in AI security tools, including new offerings from Anthropic and other AI firms. Investors fear these platforms could bypass legacy cybersecurity providers.
But Wedbush's conversations with dozens of chief information security officers and IT professionals suggest the opposite dynamic is unfolding. The firm said the emergence of AI security tools actually validates cybersecurity as "the next frontier for the AI Revolution," not a threat to incumbents.
Instead, AI is dramatically accelerating cyber threats, reducing the time needed to launch sophisticated attacks from weeks to hours. It is also expanding the number of vulnerable endpoints across cloud systems, APIs, and AI models.
Biggest Opportunity In Cybersecurity History
Wedbush believes AI represents "the biggest total addressable market opportunity to the cyber security space in its history," creating a massive demand tailwind for established leaders.
Ives continues to view CrowdStrike as the "gold standard of cybersecurity," citing its Falcon platform and strong positioning against emerging AI-driven threats.
Palo Alto Networks also remains a top pick, and Ives sees its CyberArk acquisition as a potential "game changer" as the company expands its AI security capabilities.
Zscaler, meanwhile, is seen as a "premier name to own," with rising AI adoption driving increased demand for Zero Trust and cloud security solutions.
Ives expects CrowdStrike, Palo Alto, and Zscaler to emerge as clear winners as enterprises ramp cybersecurity spending to defend against the rapidly evolving AI threat landscape. In his view, the recent selloff reflects the wrong reaction to one of the sector's biggest long-term growth opportunities.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Wall Street Stands Guard as Bessent Strikes Again: Aftereffects of August's "Treasury Turnaround" Persist, November Refinancing Notice Could Be the Next Flashpoint
As the US Treasury prepares to update its debt management plan in November, key clues may emerge on Friday.
"Coca-Cola belief" never goes out of style! KFC in America says goodbye to Pepsi and embraces Coca-Cola (KO.US); Buffett-style "boring investment" returns to the spotlight
KFC has chosen Coca-Cola as its soda supplier in the United States, abandoning its long-term partner Pepsi. As of the close of the U.S. stock market on Thursday, Coca-Cola's (KO.US) stock price reached a record high, defying the ongoing declines in global tech stocks, especially in the semiconductor and broad AI computing sectors.
AI financing concerns weigh heavily on chip stocks, global tech sector has lost over $1 trillion this week
Multiple pressures, including rising expectations of a Federal Reserve rate hike and increasing AI financing costs, have led to a massive sell-off in global tech stocks this week. The combined market value of the world's top 20 AI and semiconductor stocks has evaporated by more than $1 trillion, and the semiconductor ETF (SOXX) has recorded its longest losing streak in 11 years. On Thursday, SK Hynix continued to plunge by over 10% in a single day, while Nvidia, Samsung, and SoftBank were not spared.
Safe Haven Amid AI Crash! Major Pharmaceutical Stocks Approach Historic Highs
Amid concerns over AI capital expenditures, funds are seeking a "certainty premium." State Street Healthcare ETF reached a record high. Eli Lilly and AbbVie are both approaching their historical highest closing prices, while Gilead and Amgen have surged 7.7% and 7.2% respectively over the past five days. Eli Lilly continues to bet on the future through its GLP-1 dominance and 40 M&A deals totaling $20 billion. AbbVie's core drug Skyrizi has shown positive data for its new subcutaneous formulation, which is expected to extend its patent and drive additional sales.

